Skip to main content


Freshfields advises Frontage Holdings Corporation on Hong Kong IPO

Freshfields Bruckhaus Deringer (‘Freshfields’) has advised Frontage Holdings Corporation (‘Frontage’) on its US$200m global offering and listing of its shares on the Hong Kong Stock Exchange. Trading of the shares commenced on 30 May 2019.

Frontage is a fast-growing contract research organisation (‘CRO’) providing integrated,
scientifically-driven research, analytical and development services throughout the drug discovery and development process to enable pharmaceutical companies to achieve their drug development goals. It has operations in both China and the United States – the world’s two largest markets for CRO services.

Frontage is a subsidiary of Hangzhou Tigermed Consulting Co. Ltd., a global CRO headquartered in Hangzhou, China and is principally engaged in the provision of clinical trial services to meet the needs of pharmaceutical companies.

The Freshfields team advising on the deal was led by partners Grace Huang, Stephen Revell and David Ludwick.


Notes for editors

About Freshfields Bruckhaus Deringer

Freshfields Bruckhaus Deringer LLP is a global law firm with a long-standing track record of successfully supporting the world's leading national and multinational corporations, financial institutions and governments on ground-breaking and business-critical mandates. Our 2,800 plus lawyers deliver results worldwide through our own offices and alongside leading local firms.  Our commitment, local and multi-national expertise and business know-how means our clients rely on us when it matters most.